Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on AMPHION INNOVATIONS PLC. We currently have 11 research reports from 2 professional analysts.
|07Feb17 07:00||RNS||Additional Draw Down on Loan Facility|
|01Feb17 17:18||RNS||Holding(s) in Company|
|30Dec16 14:38||RNS||Holding(s) in Company|
|16Dec16 15:07||RNS||Director/PDMR Shareholding|
|09Dec16 15:50||RNS||Director/PDMR Shareholding|
|24Nov16 14:15||RNS||Holding(s) in Company|
|08Sep16 07:00||RNS||Re-negotiated terms of Motif CPN|
Frequency of research reports
Research reports on
AMPHION INNOVATIONS PLC
AMPHION INNOVATIONS PLC
08 Sep 16
"Equity markets globally remain in 'wait and see' mode. The overnight American and Asian markets all closed with just fractional, albeit mixed, movements as the US central bank's Beige Book, which based anecdotal feedback on economic activity collected during July and August from a dozen district banks, was seen to chant the same old lacklustre message. It noted the economy continued to expand at a modest pace and that contributors expected growth at a 'moderate' pace in the coming months, coming in tandem with a Fed Reserve report noting on Wednesday that a tight labor market and rising wages were not generating substantial inflation pressure. 'Steady as she goes' might be one interpretation, but 'clear as mud' might be another for Chair Janet Yellen who is expected to make an informed policy decision at the looming Federal Open Market Committee Meeting scheduled for 20th and 21st September. Betting right now, perhaps not surprisingly, is that rates will remain unchanged while expected data releases between now and the year-end a still expected to suggest opportunity for at least a 25bp hike, even if hawks like Jeffrey Lacker continue to bang the drum for earlier, decisive action. In the Far East, China provided the main talking point following its release of monthly export data, its traditional engine for growth, that showed a slide of 2.8% in US$-terms on last year following a 4.4% decline in July; a dull outcome, but still sufficient to beat the consensus expectations, which the Wall Street Journal polled as a 4% contraction. The ASX was the only market keen enough to make a decisive move in the region, as the commodity-led index continued to adjust to the hit on the US$ following disappointing ISM data earlier in the week, although oil futures were seen to extend gains during early morning trade following a report from the American Petroleum Institute that detailed a steep weekly draw on crude stockpiles in the US, bucking expectations of a rise and pushing prices back closer to the US$50/bbl level. Europe is in focus for macro releases this morning, with the ECB interest rate decision anticipated, along with a press conference from Mario Draghi. PM, Theresa May, is also due to meet Council President, Donald Tusk, today in London while Chancellor, Phillip Hammond, is presenting to a House of Lords Committee. Earnings figures are due form Deltex Medical (DEMG.L), Genus (GNS.L), Mattioli Woods (MTW.L) and Tower Resources (TRP.L), along with a trading statement from Dixons Carphone (DC..L). The FTSE-100 is seen opening around 8 points up this morning in relatively light volume." - Barry Gibb, Research Analyst
24 Jun 16
Leave. A scenario that mainstream City-based investors at least, entertained but never truly assumed. So the global knee-jerk reaction this morning for markets and currencies will, most certainly, be big. We can already see some of the results - In Asia, Japan's Nikkei plunged 8.2% in the early hours as the result became clear (its biggest fall in 5 years), as shares in exporting companies were forced down while the 'safe haven' Yen surged close to parity with the US cent and futures trading was suspended; shares in Hong Kong shares dropped 4.7%, although UK-exposed banks like Standard Chartered and HSBC Holdings were both hit almost twice that amount. Oil prices were also knocked in early morning trade, with Brent crude down almost 6%. Pre-opening, European shares are faced with the single thing they most dislike - uncertainty. For the UK itself, the best guess probably came from the Treasury - which sees Brexit resulting in a 3.5% hit on GDP, unemployment rising by 0.5m and house prices (key to consumer confidence) falling 10%. As far as Sterling is concerned, having instantaneously tumbled to its lowest level since 1985, Soros has already suggested that the devaluation would be 'bigger and more disruptive' that the one its suffered back on Black Wednesday. Indeed, the coming weeks and months will be difficult to predict given potential structural changes to the UK economy, as Article 50 of the Lisbon Treaty is presumably enacted and the Bank of England takes emergency measures to either protect Sterling or inject express stimulation plus liquidity into the economy, while the Prime Minister and Chancellor contemplate the extent of their remaining mandate. Worries of political contagion mean that the main European indices, like the Dax and CAC will open sharply lower, perhaps down 6% to 8%. The FTSE-100, which will suffer intense volatility throughout the trading period as investors are forced to weigh short and longer-term considerations, is seen opening down about 9%. All other background financial news effectively fades into insignificance; no macro data is scheduled for release in the UK, although data watchers may still take an interest in this morning's ifo survey release from Germany and Frances GDP data. No major UK corporates are due to report this morning."
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
N+1 Singer - N1S Trend spotting - Strategy update
08 Mar 17
In this new product we present some strategy theme updates arising out of our latest analysis of macro trends and economic data and our innovative Quant work. We also look at upcoming events and suggest topping up on some of our Best Ideas for 2017.